News
Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...
Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world’s first ...
Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced they will reduce the price of the world''s first malaria vaccine ''RTS,S'' for children developed by ...
Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...
What kind of uptake can Gilead expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) injection ...
Announcing the funds at Gavi’s global summit in Brussels, Foreign Secretary David Lammy said: “Gavi’s global impact is ...
New UK support will see millions of children vaccinated against some of the world's deadliest diseases, Foreign Secretary David Lammy announced today ...
Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...
Discover how businesses support global water goals, reducing risks and restoring ecosystems with the Freshwater Challenge by 2030.
In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...
GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock ...
Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results